The frequency of enzyme deficiency variants, defined as alleles whose products are either absent or almost devoid of normal activity in erythrocytes, was determined for nine erythrocyte enzymes in some 675 newborn infants and in approximately 200 adults. Examples of this type of genetic abnormality, which in the homozygous condition are often associated with significant health consequences, were detected for seven of the nine enzymes studied. Fifteen inherited enzyme deficiency variants in 6142 determinations from the newborn population and 5 variants in 1809 determinations from adults were identified. Seven of the deficiency variants involved triosephosphate isomerase, a frequency of0.01 in the newborn population. The average frequency of 2.4/1000 is 2-3 times the frequency observed for rare electrophoretic variants of erythrocyte enzymes in this same population.Recent years have witnessed a great wave ofenthusiasm for the electrophoretic approach as a means of defining the frequency of "occult" variation in a random sample of a plant or animal population. Strong tool though this has been, it has been recognized that this technique reveals only the tip of the iceberg, in that it fails to detect variants not associated with a charge change in the molecule under scrutiny, and it usually fails to detect variation characterized by actual or functional loss ofgene product. In this paper we will describe the results of an effort to determine the frequency ofgenetic variants resulting in total or near-total loss of activity for a series of nine human erythrocyte enzymes. We have previously reported on the frequency of rare electrophoretic variants in this sample, and in a companion paper (1) we will report the results of studies designed to estimate, for the same population and enzymes, the frequency of genetic variants exhibiting alterations in thermostability. Both investigations were undertaken in the context ofan effort to move the study of human mutation rates to the biochemical level (2).In 1932, Muller (3), in an attempt to classify types of genetic variation, distinguished between amorphs, hypomorphs, and hypermorphs. An amorph was a variant in which gene product (as then understood) was totally absent. In retrospect, Garrod in 1909 (4) defined the first amorph in man. Currently, over 100 metabolic diseases have been described in which a specific enzyme defect, either an amorph or a hypomorph in the terminology of Muller, has been identified (5-7). Almost all of these defects are detectable in the heterozygote or "carrier" individual through a significant reduction in enzyme activity, usually approaching 50% of the expected value (6). Although we have been unable to trace the origin of the term, these deficiences and in particular the amorphs, are often called "nulls."Our knowledge of the population frequency of null alleles in humans has been largely indirect, in the sense that most estimates take as their point of departure a recessively inherited disease characterized by loss of enzyme activity, fo...